Based in Saint Louis, Missouri, Stereotaxis designs, manufactures, and markets robotic systems and related instruments for use in interventional cardiology and electrophysiology procedures. The company's core offering is its robotic magnetic navigation (RMN) platform, which enables physicians to deliver catheters and guidewires through blood vessels and heart chambers using image-guided, magnetically-controlled navigation. The Genesis RMN and newer GenesisX RMN systems represent the company's primary robotic offerings, with the GenesisX designed to reduce installation complexity compared to prior generations.
The company also provides complementary products and systems supporting interventional laboratory operations. Its Odyssey platform functions as a real-time information management solution for procedure documentation and network sharing. Stereotaxis manufactures disposable devices and accessories including the QuikCAS catheter advancement device, V-CAS components, and MAGiC catheters designed for ablation procedures. The Vdrive navigation system offers stability for diagnostic and therapeutic devices during interventional procedures.
Stereotaxis operates with approximately 139 full-time employees and maintains an international distribution presence through direct sales representatives, distributors, and sales agents. The company is incorporated in Delaware and listed on the New York Stock Exchange.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.30 | $-0.30 | -11.1% | |
| 2023 | $-0.27 | $-0.27 | -3.8% | |
| 2022 | $-0.26 | $-0.26 | -62.5% | |
| 2021 | $-0.16 | $-0.16 | -45.5% | |
| 2020 | $-0.11 | $-0.11 | -10.0% | |
| 2019 | $-0.10 | $-0.10 | -233.3% | |
| 2018 | $-0.03 | $-0.03 | +90.6% | |
| 2017 | $-0.32 | $-0.32 | +40.7% | |
| 2016 | $-0.54 | $-0.54 | -54.3% | |
| 2015 | $-0.35 | $-0.35 | -975.0% | |
| 2014 | $0.04 | $0.04 | +117.4% | |
| 2013 | $-0.23 | $-0.23 | +58.2% | |
| 2012 | $-0.55 | $-0.55 | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-14 | 0001493152-25-010352 | SEC ↗ |
| 2023-12-31 | 2024-03-08 | 0001493152-24-009371 | SEC ↗ |
| 2022-12-31 | 2023-03-09 | 0001493152-23-007106 | SEC ↗ |
| 2021-12-31 | 2022-03-10 | 0001493152-22-006487 | SEC ↗ |
| 2020-12-31 | 2021-03-12 | 0001493152-21-005868 | SEC ↗ |
| 2019-12-31 | 2020-03-16 | 0001493152-20-004012 | SEC ↗ |
| 2018-12-31 | 2019-03-15 | 0001493152-19-003425 | SEC ↗ |
| 2017-12-31 | 2018-03-20 | 0001193125-18-089265 | SEC ↗ |
| 2016-12-31 | 2017-03-16 | 0001193125-17-085191 | SEC ↗ |
| 2015-12-31 | 2016-03-11 | 0001193125-16-501650 | SEC ↗ |
| 2014-12-31 | 2015-03-16 | 0001193125-15-093391 | SEC ↗ |
| 2013-12-31 | 2014-03-27 | 0001193125-14-118072 | SEC ↗ |
| 2012-12-31 | 2013-04-01 | 0001193125-13-136493 | SEC ↗ |
| 2011-12-31 | 2012-03-15 | 0001193125-12-117497 | SEC ↗ |
| 2010-12-31 | 2011-03-11 | 0001193125-11-064073 | SEC ↗ |